ArticleHeart rhythm O22025
A machine learning-based risk prediction model for atrial fibrillation in critically ill patients.
Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and risk factors for postoperative atrial fibrillation following pulmonary resection: a systematic review and meta-analysis.Journal of cardiothoracic surgery · 2026Pooled it
- Predictive value of hemoglobin-to-red cell distribution width ratio for mortality in new-onset atrial fibrillation after cardiac surgery a machine learning study based on the MIMIC-IV database.BMC cardiovascular disorders · 2026Article
- Machine Learning Prediction of ICU Mortality and Length of Stay in Atrial Fibrillation: A MIMIC-IV/MIMIC-III Study.Healthcare (Basel, Switzerland) · 2026Article
- Machine Learning Prediction of Intensive Care Unit Outcomes in Atrial Fibrillation Patients: A Rapid Review.Cureus · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atrial fibrillation (AF) in critically ill patients increases morbidity, hospital stays, and costs. Existing prediction tools are limited in intensive care unit (ICU) settings. Objective: This study developed a machine learning-based model to enable early AF risk identification and prevention. Methods: In this retrospective cohort study, adult patients admitted to the ICU were identified from the MIMIC-IV (Medical Information Mart for Intensive Care-IV) database, including 47 clinical and laboratory variables. The primary outcome was AF within the first 48 hours of admission. Multiple machine learning models were trained to predict AF, with the top-performing model undergoing hyperparameter tuning. A compact model was developed using 15 variables and 2 novel features-one identifying patients 70 years of age or older with sepsis and another representing a composite score of pre-existing cardiac risk factors. Model performance was evaluated using accuracy, area under the receiver-operating characteristic curve (AUROC), and predictive values. SHAP (Shapley Additive exPlanations) analysis interpreted individual feature contributions to the model's predictions. Results: The cohort comprised 46,266 ICU patients, with 4.6% developing AF within 48 hours. The CatBoost classifier model achieved an AUROC of 0.850 on the test set, while the compact model with new features yielded an AUROC of 0.820. SHAP analysis highlighted total serum magnesium, age, and the newly created features as key predictors of AF development. Conclusion: This study demonstrates the potential of machine learning models in predicting AF development in ICU patients. The compact model, with a satisfactory AUROC, can be a valuable tool for identifying high-risk patients and facilitating timely interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.